Akari Therapeutics' IPO

Akari Therapeutics raised a round of funding on May 15, 2013. Investors include Public.

Akari, formerly Celsus Therapeutics, is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases…

Articles about Akari Therapeutics' IPO: